# Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension

> **NCT00651859** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 111 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost 0.01% Ophthalmic Solution
- **DRUG:** Bimatoprost 0.03% Ophthalmic Solution
- **DRUG:** Bimatoprost Vehicle Ophthalmic Solution

## Key facts

- **NCT ID:** NCT00651859
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2008-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651859, "Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00651859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*